Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
ClinicalTrials.gov study NCT04070443. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT06655246. IPD Sharing: NO. Countries: 1. Publications: 0.
Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02896829. IPD Sharing: NO. Countries: 1. Publications: 0.
PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND POST-INFLAMMATORY FIBROSIS.
ClinicalTrials.gov study NCT06917196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT01011998. IPD Sharing: Not stated. Countries: 1. Publications: 0.
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
ClinicalTrials.gov study NCT00068783. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction
ClinicalTrials.gov study NCT00025415. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
ClinicalTrials.gov study NCT00403156. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year
ClinicalTrials.gov study NCT00146913. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) I
ClinicalTrials.gov study NCT00633295. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gast
ClinicalTrials.gov study NCT05152472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)
ClinicalTrials.gov study NCT00171899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
ClinicalTrials.gov study NCT02177825. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
ClinicalTrials.gov study NCT00413270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT00618501. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT00947830. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to Imatinib
ClinicalTrials.gov study NCT01400074. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Clas
ClinicalTrials.gov study NCT06124157. IPD Sharing: YES. Countries: 4. Publications: 0.
Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing Cancer
ClinicalTrials.gov study NCT00084513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response
ClinicalTrials.gov study NCT01933906. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.